XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 131 filers reported holding XENON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $5,311,000 | +104.4% | 170,000 | 0.0% | 0.17% | +116.7% |
Q3 2021 | $2,598,000 | -17.9% | 170,000 | 0.0% | 0.08% | -18.8% |
Q2 2021 | $3,165,000 | +4.0% | 170,000 | 0.0% | 0.10% | 0.0% |
Q1 2021 | $3,043,000 | +16.4% | 170,000 | 0.0% | 0.10% | +7.9% |
Q4 2020 | $2,615,000 | +38.9% | 170,000 | 0.0% | 0.09% | +15.6% |
Q3 2020 | $1,882,000 | -11.7% | 170,000 | 0.0% | 0.08% | -17.2% |
Q2 2020 | $2,132,000 | +10.6% | 170,000 | 0.0% | 0.09% | -12.3% |
Q1 2020 | $1,928,000 | -18.3% | 170,000 | -5.6% | 0.11% | +7.1% |
Q4 2019 | $2,360,000 | +45.5% | 180,000 | 0.0% | 0.10% | +41.4% |
Q3 2019 | $1,622,000 | -8.6% | 180,000 | 0.0% | 0.07% | -14.6% |
Q2 2019 | $1,775,000 | +9.2% | 180,000 | +12.5% | 0.08% | +9.3% |
Q1 2019 | $1,626,000 | +71.7% | 160,000 | +6.7% | 0.08% | +66.7% |
Q4 2018 | $947,000 | -40.2% | 150,000 | +25.0% | 0.04% | -37.5% |
Q3 2018 | $1,584,000 | – | 120,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |